Sarah L. Trinder

743 total citations · 1 hit paper
13 papers, 577 citations indexed

About

Sarah L. Trinder is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sarah L. Trinder has authored 13 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Pathology and Forensic Medicine and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sarah L. Trinder's work include Pulmonary Hypertension Research and Treatments (9 papers), Systemic Sclerosis and Related Diseases (5 papers) and Connective Tissue Growth Factor Research (2 papers). Sarah L. Trinder is often cited by papers focused on Pulmonary Hypertension Research and Treatments (9 papers), Systemic Sclerosis and Related Diseases (5 papers) and Connective Tissue Growth Factor Research (2 papers). Sarah L. Trinder collaborates with scholars based in United Kingdom, United States and Germany. Sarah L. Trinder's co-authors include Alan Holmes, Christopher P. Denton, A Gilbane, David Abraham, Robert B. Good, Gerry Coghlan, Reshma S. Baliga, Adrian J. Hobbs, Raymond J. MacAllister and Suborno M. Ghosh and has published in prestigious journals such as Circulation, American Journal of Respiratory and Critical Care Medicine and American Journal Of Pathology.

In The Last Decade

Sarah L. Trinder

10 papers receiving 573 citations

Hit Papers

Endothelial to Mesenchyma... 2015 2026 2018 2022 2015 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension
    2015 274 citations Robert B. Good, A Gilbane et al. American Journal Of Pathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah L. Trinder United Kingdom 8 305 221 149 102 95 13 577
Karpagam Aravindhan United States 10 143 0.5× 248 1.1× 196 1.3× 65 0.6× 79 0.8× 11 666
Alan R. Olzinski United Kingdom 15 168 0.6× 238 1.1× 148 1.0× 106 1.0× 27 0.3× 19 680
Mar Orriols Spain 14 241 0.8× 285 1.3× 139 0.9× 40 0.4× 21 0.2× 20 635
Ekaterina Legchenko Germany 10 357 1.2× 307 1.4× 230 1.5× 57 0.6× 19 0.2× 20 737
Hitoshi Horimoto Japan 11 131 0.4× 113 0.5× 121 0.8× 62 0.6× 132 1.4× 27 444
Motoi Okada Japan 15 99 0.3× 369 1.7× 135 0.9× 115 1.1× 42 0.4× 39 738
Hyoe Inomata Japan 9 187 0.6× 285 1.3× 53 0.4× 95 0.9× 20 0.2× 11 625
Hiromasa Fujii Japan 13 165 0.5× 232 1.0× 48 0.3× 33 0.3× 34 0.4× 60 454
Monika Maleszewska Germany 9 112 0.4× 497 2.2× 85 0.6× 53 0.5× 38 0.4× 13 730
Hakuoh Konishi Japan 11 70 0.2× 145 0.7× 167 1.1× 114 1.1× 22 0.2× 24 517

Countries citing papers authored by Sarah L. Trinder

Since Specialization
Citations

This map shows the geographic impact of Sarah L. Trinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah L. Trinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah L. Trinder more than expected).

Fields of papers citing papers by Sarah L. Trinder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah L. Trinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah L. Trinder. The network helps show where Sarah L. Trinder may publish in the future.

Co-authorship network of co-authors of Sarah L. Trinder

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah L. Trinder. A scholar is included among the top collaborators of Sarah L. Trinder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah L. Trinder. Sarah L. Trinder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Papaioannou, Ioannis, Athina Dritsoula, Ping Kang, et al.. (2024). NKX2-5 regulates vessel remodeling in scleroderma-associated pulmonary arterial hypertension. JCI Insight. 9(10).
2.
Tam, Angela, Sarah L. Trinder, Korsa Khan, et al.. (2021). Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension. The International Journal of Biochemistry & Cell Biology. 134. 105961–105961. 19 indexed citations
3.
Trinder, Sarah L., Myriam Labelle, Manuel Rodriguez‐Justo, et al.. (2020). Platelet‐derived transforming growth factor‐β1 promotes keratinocyte proliferation in cutaneous wound healing. Journal of Tissue Engineering and Regenerative Medicine. 14(4). 645–649. 45 indexed citations
4.
Gilbane, A, Emma Derrett‐Smith, Sarah L. Trinder, et al.. (2015). Impaired Bone Morphogenetic Protein Receptor II Signaling in a Transforming Growth Factor-β–Dependent Mouse Model of Pulmonary Hypertension and in Systemic Sclerosis. American Journal of Respiratory and Critical Care Medicine. 191(6). 665–677. 38 indexed citations
5.
Feeney, Maria, Farhan Syed, Khaleque Newaz Khan, et al.. (2015). Oncostatin M As a Potential Molecular Target in Systemic Sclerosis. UCL Discovery (University College London). 4 indexed citations
6.
Good, Robert B., A Gilbane, Sarah L. Trinder, et al.. (2015). Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension. American Journal Of Pathology. 185(7). 1850–1858. 274 indexed citations breakdown →
7.
Trinder, Sarah L., et al.. (2014). Dysfunctional Endothelial Progenitor Cells may Contribute to Vasculopathy in Systemic Sclerosis. European Journal of Vascular and Endovascular Surgery. 47(6). 694–694. 1 indexed citations
8.
Bubb, Kristen J., Sarah L. Trinder, Reshma S. Baliga, et al.. (2014). Inhibition of Phosphodiesterase 2 Augments cGMP and cAMP Signaling to Ameliorate Pulmonary Hypertension. Circulation. 130(6). 496–507. 61 indexed citations
9.
Baliga, Reshma S., Chris J. Scotton, Sarah L. Trinder, et al.. (2014). Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis. British Journal of Pharmacology. 171(14). 3463–3475. 11 indexed citations
10.
Derrett‐Smith, Emma, Audrey Dooley, A Gilbane, et al.. (2013). Endothelial Injury in a Transforming Growth Factor β–Dependent Mouse Model of Scleroderma Induces Pulmonary Arterial Hypertension. Arthritis & Rheumatism. 65(11). 2928–2939. 40 indexed citations
11.
Baliga, Reshma S., Alexandra Milsom, Suborno M. Ghosh, et al.. (2012). Dietary Nitrate Ameliorates Pulmonary Hypertension. Circulation. 125(23). 2922–2932. 84 indexed citations
12.
Baliga, Reshma S., Sarah L. Trinder, Chris J. Scotton, et al.. (2009). Manipulating the natriuretic peptide system for the treatment of pulmonary hypertension. BMC Pharmacology. 9(S1).
13.
Staszewski, Schlomo, Sarah L. Trinder, Volkmar Jacobi, et al.. (1990). [Prospective study of primary and secondary prevention of Pneumocystis carinii pneumonia with pentamidine aerosol].. PubMed. 85 Suppl 2. 271–5.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karpagam Aravindhan Breakdown of academic impact, for papers by Alan R. Olzinski Breakdown of academic impact, for papers by Mar Orriols Breakdown of academic impact, for papers by Ekaterina Legchenko Breakdown of academic impact, for papers by Hitoshi Horimoto Breakdown of academic impact, for papers by Motoi Okada Breakdown of academic impact, for papers by Hyoe Inomata Breakdown of academic impact, for papers by Hiromasa Fujii Breakdown of academic impact, for papers by Monika Maleszewska Breakdown of academic impact, for papers by Hakuoh Konishi
Rankless by CCL
2026